M Volm

7.9k total citations
278 papers, 6.5k citations indexed

About

M Volm is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, M Volm has authored 278 papers receiving a total of 6.5k indexed citations (citations by other indexed papers that have themselves been cited), including 148 papers in Molecular Biology, 117 papers in Oncology and 66 papers in Pulmonary and Respiratory Medicine. Recurrent topics in M Volm's work include Drug Transport and Resistance Mechanisms (56 papers), Lung Cancer Treatments and Mutations (47 papers) and Cancer therapeutics and mechanisms (38 papers). M Volm is often cited by papers focused on Drug Transport and Resistance Mechanisms (56 papers), Lung Cancer Treatments and Mutations (47 papers) and Cancer therapeutics and mechanisms (38 papers). M Volm collaborates with scholars based in Germany, Hungary and United States. M Volm's co-authors include Reet Koomägi, J Mattern, Thomas Efferth, Jürgen Mattern, K. Wayss, G. Stammler, Axel Sauerbrey, P. Drings, F Zintl and Werner Rittgen and has published in prestigious journals such as Nature, JNCI Journal of the National Cancer Institute and Cancer.

In The Last Decade

M Volm

266 papers receiving 6.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M Volm Germany 40 3.6k 3.0k 1.5k 1.2k 474 278 6.5k
Janet A. Houghton United States 46 4.3k 1.2× 3.0k 1.0× 899 0.6× 795 0.7× 393 0.8× 144 6.5k
Youcef M. Rustum United States 51 3.5k 1.0× 3.7k 1.2× 1.1k 0.7× 1.3k 1.1× 865 1.8× 246 8.2k
Anderson J. Ryan United Kingdom 42 3.9k 1.1× 2.9k 1.0× 1.5k 1.0× 1.4k 1.2× 355 0.7× 159 7.4k
Niramol Savaraj United States 47 3.2k 0.9× 2.4k 0.8× 1.7k 1.2× 741 0.6× 367 0.8× 211 6.9k
Massimo Broggini Italy 48 4.8k 1.3× 3.1k 1.0× 1.4k 0.9× 1.1k 1.0× 312 0.7× 236 7.6k
William P. Tong United States 40 3.6k 1.0× 2.1k 0.7× 641 0.4× 1.4k 1.2× 600 1.3× 110 6.6k
Raymond E. Meyn United States 49 4.5k 1.2× 2.5k 0.8× 1.6k 1.0× 874 0.7× 359 0.8× 135 7.0k
Shin‐ichi Akiyama Japan 41 2.7k 0.7× 2.2k 0.7× 1.1k 0.8× 583 0.5× 488 1.0× 194 5.3k
Tona M. Gilmer United States 30 4.0k 1.1× 3.8k 1.2× 850 0.6× 1.2k 1.1× 182 0.4× 60 6.8k
Rolf Lewensohn Sweden 42 3.1k 0.9× 2.0k 0.7× 1.3k 0.8× 2.3k 2.0× 526 1.1× 223 7.1k

Countries citing papers authored by M Volm

Since Specialization
Citations

This map shows the geographic impact of M Volm's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M Volm with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M Volm more than expected).

Fields of papers citing papers by M Volm

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M Volm. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M Volm. The network helps show where M Volm may publish in the future.

Co-authorship network of co-authors of M Volm

This figure shows the co-authorship network connecting the top 25 collaborators of M Volm. A scholar is included among the top collaborators of M Volm based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M Volm. M Volm is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Efferth, Thomas, V. Badireenath Konkimalla, Yi‐Fen Wang, et al.. (2008). Prediction of Broad Spectrum Resistance of Tumors towards Anticancer Drugs. Clinical Cancer Research. 14(8). 2405–2412. 149 indexed citations
2.
Volm, M & Thomas Efferth. (2008). Resistenzüberwindung bei Tumoren. DMW - Deutsche Medizinische Wochenschrift. 119(13). 475–479.
3.
Koomägi, Reet & M Volm. (1999). Expression of FAS (CD95/APO‐1) and FAS ligand in lung cancer, its prognostic and predictive relevance. International Journal of Cancer. 84(3). 239–243. 5 indexed citations
4.
Volm, M, et al.. (1997). Prognostic value of vascular endothelial growth factor and its receptor Flt-1 in squamous cell lung cancer. International Journal of Cancer. 74(1). 64–68. 184 indexed citations
5.
Volm, M, et al.. (1997). Prognostic value of vascular endothelial growth factor and its receptor Flt‐1 in squamous cell lung cancer. International Journal of Cancer. 74(1). 64–68. 11 indexed citations
6.
7.
Volm, M, et al.. (1997). Expression of lung resistance-related protein (LRP) in initial and relapsed childhood acute lymphoblastic leukemia. Anti-Cancer Drugs. 8(7). 662–665. 19 indexed citations
8.
Volm, M, Reet Koomägi, Manfred Kaufmann, Jürgen Mattern, & G. Stammler. (1996). Microvessel density, expression of proto-oncogenes, resistance-related proteins and incidence of metastases in primary ovarian carcinomas. Clinical & Experimental Metastasis. 14(3). 209–214. 12 indexed citations
9.
Volm, M, et al.. (1995). Reversal of doxorubicin-resistance in solid tumors by clomipramine.. PubMed. 9(2). 99–101. 15 indexed citations
10.
Volm, M, G. van Kaick, & Jürgen Mattern. (1994). Analysis of c-fos, c-jun, c-erbB1, c-erbB2 and c-myc in primary lung carcinomas and their lymph node metastases. Clinical & Experimental Metastasis. 12(4). 329–334. 38 indexed citations
11.
12.
Volm, M. (1993). P-glycoprotein associated expression of c-fos and c-jun products in human lung carcinomas.. PubMed. 13(2). 375–8. 15 indexed citations
13.
Efferth, Thomas & M Volm. (1993). Increase of alkaline phosphatase in multidrug-resistant tumor cells and their cross-resistance to 6-thioguanine.. PubMed. 43(10). 1118–21. 6 indexed citations
14.
15.
Volm, M & Thomas Efferth. (1990). Relationship of DNA ploidy to chemoresistance of tumors as measured by in vitro tests. Cytometry. 11(3). 406–410. 14 indexed citations
16.
Wayss, K., et al.. (1982). Polysomal polyadenylated RNA and albumin messenger RNA in Mastomys liver and in a chemically induced hepatocellular carcinoma.. PubMed. 42(5). 1986–93. 1 indexed citations
17.
Kaufmann, Michael, et al.. (1978). [Short-term incubation in vitro with precursors of nucleic acids on human primary tumors and metastases of carcinoma of the breast (author's transl)].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 154(4). 277–81. 4 indexed citations
18.
Volm, M, Horst-Dieter Hummel, & J Mattern. (1977). �bereinstimmung von Zytostatikaeffekten in vivo und im Kurzzeittest (in vitro) bei der Leuk�mie L 1210. Annals of Hematology. 35(1). 65–74.
19.
Wayss, K., J Mattern, & M Volm. (1975). [Correlation of in vitro testing and therapeutical results in animal transplanted tumors after cytostatic treatment].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 25(1). 77–81. 1 indexed citations
20.
Volm, M, et al.. (1970). Vereinfachte Methode zur Erfassung toxischer Effekte bei hämorrhagischen Zellsuspensionen. Annals of Hematology. 20(6). 377–382. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Janet A. Houghton Breakdown of academic impact, for papers by Youcef M. Rustum Breakdown of academic impact, for papers by Anderson J. Ryan Breakdown of academic impact, for papers by Niramol Savaraj Breakdown of academic impact, for papers by Massimo Broggini Breakdown of academic impact, for papers by William P. Tong Breakdown of academic impact, for papers by Raymond E. Meyn Breakdown of academic impact, for papers by Shin‐ichi Akiyama Breakdown of academic impact, for papers by Tona M. Gilmer Breakdown of academic impact, for papers by Rolf Lewensohn
Rankless by CCL
2026